JLE

European Journal of Dermatology

MENU

Application of hair transplantation combined with platelet-rich plasma injection for the treatment of androgenic alopecia Volume 33, numéro 5, September-October 2023

  • [1] Altun E, Yaylı S, Aksu Arıca D, Baykal Selcuk L, Bahadır S. Retrospective analysis of methylprednisolone treatment alone and in combination with methotrexate in patients with extensive alopecia areata. Dermatol Ther. 2022;35. e15776
  • [2] Babadjouni A, Phong CH, Nguyen C, Mesinkovska NA. COVID-19 vaccination related exacerbations of hair loss in patients with moderate to severe alopecia areata on systemic therapy. JAAD Case Rep. 2022;29:181-5.
  • [3] Chen X, Xiang H, Yang M. Topical cetirizine for treating androgenetic alopecia: a systematic review. J Cosmet Dermatol. 2022;21:5519-26.
  • [4] João AL, Cunha N, Pinheiro RR, Lencastre A. Dermatitis cruris pustulosa et atrophicans: scarring alopecia beyond scalp hair. Skin Appendage Disord. 2022;8:280-6.
  • [5] Rodríguez-Cuadrado FJ, Pinto-Pulido EL, Fernández-Parrado M. Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature. Eur J Dermatol. 2023;33:72.
  • [6] Woods RH. Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: a pharmacovigilance study. Pharmacotherapy. 2022.
  • [7] Cedirian S, Bruni F, Quadrelli F. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia. J Cosmet Dermatol. 2023.
  • [8] Xiao R, Burks CA, Yau J. Health utility measures among patients with androgenetic alopecia after hair transplant. Aesthetic Plast Surg. 2023;47:631-9.
  • [9] Balazic E, Axler E, Nwankwo C. Minimizing bias in alopecia diagnosis in skin of color patients. J Drugs Dermatol. 2023;22:703-5.
  • [10] O’Hagan R, Caldas SA, Correa da Rosa JM, Guttman-Yassky E, Ungar B. Alopecia areata is associated with increased genetic risk of myocardial infarction: a Mendelian randomization study. J Eur Acad Dermatol Venereol. 2023.
  • [11] Gentile P. Hair loss and telogen effluvium related to COVID-19: the potential implication of adipose-derived mesenchymal stem cells and platelet-rich plasma as regenerative strategies. Int J Mol Sci. 2022;23:9116.
  • [12] Jin P, Wei L, Zhang Q. Dupilumab for alopecia areata treatment: a double-edged sword? J Cosmet Dermatol. 2022;21:5546-8.
  • [13] Klein E, Karim M, Kim R, Lo Sicco K, Shapiro J. Reversible hair loss in lichen planopilaris: regrowth with low-dose naltrexone and platelet-rich plasma. J Drugs Dermatol. 2022;21:671-3.
  • [14] Sasaki GH. Response to: the emperor has no platelets: minimal effects in an alopecia split-scalp study unsurprising as platelet-rich plasma was actually platelet-poor. Aesthet Surg J. 2022;42:NP802-3.
  • [15] Larrondo J, Petela J, McMichael AJ. Transitory hair growth using platelet-rich plasma therapy in stabilized CCCA. Dermatol Ther. 2022. e15798
  • [16] Meznerics FA, Illés K, Dembrovszky F. Platelet-rich plasma in alopecia areata-a steroid-free treatment modality: a systematic review and meta-analysis of randomized clinical trials. Biomedicine. 2022;10:1829.
  • [17] Pachar S, Chouhan C, Rao P, Kachhawa D, Singh H, Yadav C. A comparative study of efficacy of 5% minoxidil and 5% minoxidil plus platelet-rich plasma in same patient for treatment of androgenetic alopecia. J Cutan Aesthet Surg. 2022;15:71-6.
  • [18] Elariny AF, Ghozlan N, Wasief S, Moussa AE, Eldeeb ME. Evaluation of efficacy of follicular unit extraction versus follicular unit extraction with platelet rich plasma in treatment of cicatricial alopecia. J Cosmet Dermatol. 2022;21:5931-7.
  • [19] Avram MR, Finney R, Rogers N. Hair transplantation controversies. Dermatol Surg. 2017;43:S158-62.
  • [20] Bared A. Beard hair transplantation. Facial Plast Surg Clin North Am. 2020;28:237-41.
  • [21] Collins K, Avram MR. Hair transplantation and follicular unit extraction. Dermatol Clin. 2021;39:463-78.
  • [22] Fu D, Huang J, Li K. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia. Biomed Pharmacother. 2021;137:111247.
  • [23] Audickaite A, Alam M, Jimenez F. Eyebrow hair transplantation in frontal fibrosing alopecia: pitfalls of short- and long-term results. Dermatol Surg. 2020;46:922-5.
  • [24] Agaoglu G, Özer F, Karademir S, Agaoglu E, Erol O. Hair transplantation in burn scar alopecia after combined non-ablative fractional laser and microfat graft treatment. Aesthet Surg J. 2021;41:NP1382-90.
  • [25] Reyes-Hadsall S, Drake L, Han JJ. Shared decision-making, therapeutic choice, and decisional regret in patients with alopecia areata. JAMA Dermatol. 2022;158:1187-91.
  • [26] Sarikaya Solak S, Sezer BE, Anzerlioglu M, Tokmak Z, Topuz C. Multiple clinical manifestations of lichenoid spectrum: a patient with frontal fibrosing alopecia, lichen planus pigmentosus, and nail lichen planus. Skin Appendage Disord. 2022;8:333-7.
  • [27] Samrao A, Mirmirani P. Postpartum telogen effluvium unmasking traction alopecia. Skin Appendage Disord. 2022;8:328-32.
  • [28] Mudraje S, Shetty S, Guruvare S, Kudva R. Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia. BMJ Case Rep. 2022;15. e249324
  • [29] Rosales Santillan M, Goldberg JB, Goldberg LJ. Exploring potential decreasing age of patients with frontal fibrosing alopecia. JAAD Int. 2022;9:28-9.
  • [30] Girijala RL, Riahi RR, Cohen PR. Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review. Dermatol Online J. 2018;24. 13030/qt8s43026c
  • [31] Martinez-Lopez A, Montero-Vilchez T, Sierra-Sánchez Á, Molina-Leyva A, Arias-Santiago S. Advanced medical therapies in the management of non-scarring alopecia: areata and androgenic alopecia. Int J Mol Sci. 2020;21:8390.
  • [32] McElwee KJ, Shapiro JS. Promising therapies for treating and/or preventing androgenic alopecia. Skin Therapy Lett. 2012;17:1-4.
  • [33] Motofei IG, Rowland DL, Tampa M. Finasteride and androgenic alopecia; from therapeutic options to medical implications. J Dermatolog Treat. 2020;31:415-21.
  • [34] Asnaashari S, Javadzadeh Y. Herbal medicines for treatment of androgenic alopecia. Altern Ther Health Med. 2020;26:27-35.
  • [35] Almohanna HM, Ahmed AA, Griggs JW, Tosti A. Platelet-rich plasma in the treatment of alopecia areata: a review. J Investig Dermatol Symp Proc. 2020;20:S45-9.
  • [36] Emer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett. 2019;24:1-6.
  • [37] Gentile P, Garcovich S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil(®), finasteride(®), and adult stem cell-based therapy. Int J Mol Sci. 2020;21:2702.
  • [38] Gan YY, Du LJ, Hong WJ, Hu ZQ, Miao Y. Theoretical basis and clinical practice for FUE megasession hair transplantation in the treatment of large area androgenic alopecia. J Cosmet Dermatol. 2021;20:210-7.
  • [39] Gentile P, Garcovich S. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cell. 2019;8:466.
  • [40] Ishii LE, Lee LN. Hair transplantation: advances in diagnostics, artistry, and surgical techniques. Facial Plast Surg Clin North Am. 2020;28:xi-xii.
  • [41] Kumar AR, Ishii LE. Hair transplantation for scarring alopecia. Facial Plast Surg Clin North Am. 2020;28:177-9.
  • [42] Madura C, Harsha S, Kusuma MR, Chandrashekar BS. Hair transplantation for radiation-induced alopecia. Dermatol Surg. 2021;47:1307-9.
  • [43] Jimenez F, Alam M, Vogel JE, Avram M. Hair transplantation: basic overview. J Am Acad Dermatol. 2021;85:803-14.